Article
From adjuvant to preventive breast cancer treatment: bridging the gap over troubled waters.
Annals of oncology : official journal of the European Society for Medical Oncology - 1 Jun 2006
Ricevuto E, Di Rocco Z C, Sidoni T, Ficorella C, Porzio G, Pujol P, Adamo B, Majorana O, Marchetti P
Abstract excerpt
Recently, chemoprevention trials have demonstrated the efficacy of preventive medical treatment (PMT) in reducing breast cancer (BC) detection rates in at-risk affected and unaffected women selected according to clinical and/or familial risk criteria, particularly with the use of tamoxifen (TAM). Major concerns limiting the routine use of TAM are the questionable benefit/risk ratio and poor patient compliance,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.